Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹18735 Cr.
Stock P/E
34.8
P/B
1.9
Current Price
₹40
Book Value
₹ 20.6
Face Value
10
52W High
₹57.9
52W Low
₹ 35.8
Dividend Yield
0.37%

Sagility Overview

Here's a structured overview of Sagility Ltd.:

Important Note regarding Ticker:

Sagility Ltd. was formed from the healthcare services business of Hinduja Global Solutions (HGS) which was acquired by Baring Private Equity Asia (now EQT Private Equity Asia) in 2021. As such, Sagility Ltd. is currently a privately held company under the ownership of EQT Private Equity Asia and does not trade publicly under the ticker "SAGILITY" on Indian exchanges or elsewhere. This analysis will proceed based on Sagility Ltd. as a privately held entity focused on healthcare BPM services.

1. Business Overview

Sagility Ltd. is a global leader in healthcare business process management (BPM) and digital transformation services. The company partners with healthcare payers, providers, and pharmacy benefits managers (PBMs) to optimize their operations, enhance customer experience, and drive digital innovation. Sagility provides a comprehensive suite of services including back-office support, claims processing, member enrollment, provider data management, clinical process management, customer service, and technology solutions like automation and AI. Its core business model revolves around long-term service contracts, leveraging its deep domain expertise and global delivery capabilities (primarily from India) to provide cost-effective and specialized solutions. Sagility makes money by charging fees for these services, helping clients reduce costs, improve efficiency, and navigate complex healthcare regulations.

2. Key Segments / Revenue Mix

Sagility primarily serves the healthcare sector across three main client segments:

Payers: Health insurance companies, managed care organizations, and government healthcare programs. Services include claims administration, member services, enrollment, and compliance.

Providers: Hospitals, clinics, physician groups, and other healthcare facilities. Services include revenue cycle management, patient engagement, and clinical support.

Pharmacy Benefits Managers (PBMs): Companies that manage prescription drug benefits for health plans. Services involve formulary management, claims processing, and patient support.

While specific revenue contributions per segment are not publicly disclosed for the privately held entity, the company's focus is holistic, offering end-to-end solutions across these key areas of the healthcare ecosystem.

3. Industry & Positioning

Sagility operates within the highly specialized and competitive global healthcare BPM and IT services industry. This industry is characterized by increasing demand for digital transformation, cost optimization, and regulatory compliance among healthcare organizations worldwide. Key drivers include aging populations, rising healthcare costs, and evolving regulatory landscapes (especially in the US, which is a major market for healthcare BPM).

Sagility positions itself as a specialized, domain-focused player within this industry. It competes with:

Large, diversified IT services firms: Companies like TCS, Wipro, Infosys, HCLTech, and Cognizant, which have large healthcare verticals.

Other specialized healthcare BPO providers: Niche players focused exclusively on healthcare.

Sagility differentiates itself through its deep understanding of healthcare processes, regulatory expertise, and ability to deliver integrated technology-enabled solutions. It leverages India's talent pool for cost-effective delivery while focusing on value-added services.

4. Competitive Advantage (Moat)

Sagility possesses several competitive advantages:

Specialized Domain Expertise: Deep knowledge of complex healthcare regulations (e.g., HIPAA in the US), clinical processes, and industry-specific workflows creates high barriers to entry for generalist providers.

Switching Costs: Once a service provider is integrated into a client's core operational processes (e.g., claims processing, revenue cycle management), switching to a new vendor can be expensive, disruptive, and risky due to data migration, process re-engineering, and compliance concerns.

Client Relationships: Long-standing relationships with key healthcare payers and providers build trust and recurring revenue streams.

Global Delivery Model: Leveraging a skilled talent pool in India and other locations allows for cost-effective service delivery, providing a competitive pricing advantage.

5. Growth Drivers

Key factors that can drive Sagility's growth over the next 3-5 years include:

Digital Transformation in Healthcare: Increasing adoption of automation, AI, analytics, and cloud solutions by healthcare organizations to improve efficiency and patient outcomes.

Cost Containment Pressures: Healthcare clients constantly seek to reduce operational costs, driving outsourcing and process optimization.

Regulatory Complexity: Evolving healthcare policies and compliance requirements necessitate specialized expertise that companies like Sagility can provide.

Expansion of Services: Opportunities to upsell and cross-sell new digital and analytics services to existing clients and expand into new sub-segments within healthcare.

Geographic Expansion: Potential for growth in new markets beyond its current primary focus areas.

Aging Global Population: Drives increasing demand for healthcare services, which in turn fuels demand for supporting BPM functions.

6. Risks

Sagility faces several key business risks:

Client Concentration: Dependence on a few large healthcare clients for a significant portion of its revenue can pose a risk if a major contract is lost or reduced.

Regulatory Changes: Significant changes in healthcare policy (especially in the US) could impact client demand, operational requirements, and profitability.

Talent Attrition & Wage Inflation: Intense competition for skilled professionals in India and other delivery locations can lead to higher wage costs and difficulty retaining talent.

Technological Disruption: Failure to continuously innovate and adapt to rapidly evolving technologies (e.g., generative AI, advanced analytics) could erode its competitive edge.

Data Security & Compliance Breaches: Handling sensitive protected health information (PHI) exposes the company to severe reputational and financial damage from data breaches or non-compliance.

Intense Competition: The industry is highly competitive, potentially leading to pricing pressures and margin erosion.

Currency Fluctuations: As a company with significant global revenues and costs, it is exposed to foreign exchange rate volatility, particularly USD-INR movements.

7. Management & Ownership

Sagility Ltd. is owned by EQT Private Equity Asia (formerly Baring Private Equity Asia), a prominent global private equity firm. The management team typically comprises experienced professionals from the IT and BPM services industry, often with a strong background in healthcare. Under private equity ownership, the management is usually focused on driving operational efficiency, strategic growth initiatives, and preparing the company for a potential future exit (e.g., an IPO or sale). The ownership structure by EQT suggests a focus on value creation, leveraging strategic investments in technology, talent, and market expansion.

8. Outlook

Sagility benefits from a robust and growing healthcare BPM market, driven by secular trends in digital transformation, cost optimization, and regulatory demands. Its specialized focus within healthcare provides a defensible niche, supported by high switching costs and deep domain expertise. The backing of EQT Private Equity Asia typically implies strategic investments aimed at accelerating growth and operational excellence.

However, the company operates in a highly competitive environment. Managing client concentration risk, staying ahead of rapid technological advancements, and navigating evolving healthcare regulations will be crucial. Talent retention and wage inflation pressures in key delivery geographies also pose ongoing challenges. The outlook suggests continued growth, contingent on effective execution of its digital transformation strategy and successful management of competitive and operational risks within its specialized healthcare niche.

Sagility Share Price

Live · BSE / NSE · Inception: 2021
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Sagility Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 1260 1283 1223 1325 1453 1568 1539 1658 1971 2024
Other Income 6 5 24 15 44 10 10 58 8 25
Total Income 1266 1288 1248 1340 1497 1579 1549 1717 1980 2049
Total Expenditure 1000 976 1029 1024 1061 1195 1193 1243 1460 1540
Operating Profit 266 312 218 316 436 383 356 473 520 509
Interest 47 43 37 30 30 30 27 25 25 22
Depreciation 176 176 110 126 116 114 118 122 124 124
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 -33 0
Profit Before Tax 44 93 71 160 290 239 210 327 339 363
Provision for Tax -27 13 49 43 73 56 62 76 71 105
Profit After Tax 71 80 22 117 217 183 149 251 268 258
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 71 80 22 117 217 183 149 251 268 258
Adjusted Earnings Per Share 0.4 0.2 0 0.3 0.5 0.4 0.3 0.5 0.6 0.6

Sagility Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 923 4218 4754 5570 7192
Other Income 21 18 31 56 101
Total Income 944 4236 4784 5626 7295
Total Expenditure 734 3191 3668 4272 5436
Operating Profit 211 1045 1116 1354 1858
Interest 65 215 185 127 99
Depreciation 147 644 689 467 488
Exceptional Income / Expenses 0 0 0 0 -33
Profit Before Tax -2 186 242 760 1239
Provision for Tax 3 42 13 221 314
Profit After Tax -5 144 228 539 926
Adjustments 0 0 0 0 0
Profit After Adjustments -5 144 228 539 926
Adjusted Earnings Per Share -0 0.7 0.5 1.2 2

Sagility Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 4027 6207 6443 8336
Minority's Interest 0 0 0 0
Borrowings 4184 2324 1665 567
Other Non-Current Liabilities 989 942 969 925
Total Current Liabilities 885 1056 1452 1089
Total Liabilities 10085 10529 10529 10917
Fixed Assets 8621 8607 8667 8997
Other Non-Current Assets 58 129 142 99
Total Current Assets 1406 1793 1720 1821
Total Assets 10085 10529 10529 10917

Sagility Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 374 585 344
Cash Flow from Operating Activities -32 857 973 1214
Cash Flow from Investing Activities -7714 -129 -469 -964
Cash Flow from Financing Activities 8116 -545 -751 -256
Net Cash Inflow / Outflow 370 183 -247 -6
Closing Cash & Cash Equivalent 374 585 344 344

Sagility Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0.02 0.75 0.53 1.15
CEPS(Rs) 0.74 4.11 2.14 2.15
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) -13.92 -2.56 15.04 17.54
Core EBITDA Margin(%) 20.53 24.35 22.83 23.3
EBIT Margin(%) 6.86 9.49 8.98 15.93
Pre Tax Margin(%) -0.2 4.4 5.08 13.65
PAT Margin (%) -0.51 3.4 4.8 9.68
Cash Profit Margin (%) 15.44 18.68 19.3 18.06
ROA(%) -0.05 1.39 2.17 5.03
ROE(%) 0 0 7.67 7.36
ROCE(%) 0.77 4.78 5.06 10.14
Receivable days 366.1 86.3 86.38 80.21
Inventory Days 0 0 0 0
Payable days 0 0 0 0
PER(x) 0 0 0 37.29
Price/Book(x) 0 0 0 2.45
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 6.2 0.87 1.23 3.69
EV/Core EBITDA(x) 27.21 3.5 5.25 15.19
Net Sales Growth(%) 0 356.83 12.69 17.17
EBIT Growth(%) 0 532.12 6.57 107.89
PAT Growth(%) 0 3173.69 58.99 136.18
EPS Growth(%) 0 3179.42 -28.81 116.29
Debt/Equity(x) -1.57 -4.73 0.3 0.1
Current Ratio(x) 1.59 1.7 1.18 1.67
Quick Ratio(x) 1.59 1.7 1.18 1.67
Interest Cover(x) 0.97 1.86 2.31 6.98
Total Debt/Mcap(x) 0 0 0 0.04

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +17% +82%
Operating Profit CAGR +21% +86%
PAT CAGR +136%
Share Price CAGR +3%
ROE Average +7% +5% +4% +4%
ROCE Average +10% +7% +5% +5%

Sagility Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 50.95 %
FII 10.02 %
DII (MF + Insurance) 22.29 %
Public (retail) 49.05 %
# Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 82.3982.3967.3867.3850.9550.95
FII 3.783.395.995.5910.2510.02
DII 7.257.4814.0614.8821.3622.29
Public 17.6117.6132.6232.6249.0549.05
Others 000000
Total 100100100100100100

Sagility Peer Comparison

Business Support Edit Columns

Sagility Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Sagility Pros & Cons

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 5% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp